Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug

1. A taxane-containing amphiphilic block copolymer micelle formation aqueous solution, consisting of 1.0-15 wt % of paclitaxel or docetaxel, 20-98wt % of an amphiphilic block copolymer containing a hydrophilic block (A) and a hydrophobic block (B), and 1.0-10 wt % of sodium chloride, in an aqueous ethanol solution, wherein the weight percentages are based on the total dry weight of the taxane-containing amphiphilic block copolymer micelle aqueous solution,

wherein the hydrophilic block (A) is polyethylene glycol or monomethoxypolyethylene glycol having a weight average molecular weight of 1,000-2,500 daltons, and the hydrophobic block (B) is polylactic acid (PLA) or a copolymer of polylactic acid and glycolic acid (PLGA) having a weight average molecular weight of 1,000-2,500 daltons, and

wherein the amphiphilic block copolymer comprises 50-60 wt % of the hydrophilic block (A) and 40-50 wt % of the hydrophobic block (B).

2. A reconstituted taxane-containing amphiphilic block copolymer micelle aqueous solution for intravenous infusion, consisting of 0.1-15 wt % of paclitaxel or docetaxel, based on the total dry weight of the aqueous solution, 10-150 mg/ml of an amphiphilic block copolymer containing a hydrophilic block (A) and a hydrophobic block (B), 5-30 mg/ml of sodium chloride, and 1-100 mg/ml of lactose or mannitol,

wherein the hydrophilic block (A) is polyethylene glycol or monomethoxypolyethylene glycol having a weight average molecular weight of 1,000-2,500 daltons, and the hydrophobic block (B) is polylactic acid (PLA) or a copolymer of polylactic acid and glycolic acid (PLGA) having a weight average molecular weight of 1,000-2,500 daltons, and

wherein the amphiphilic block copolymer comprises 50-60 wt % of the hydrophilic block (A) and 40-50 wt % of the hydrophobic block (B).